Amgen at AHA Scientific Sessions 2014

Amgen will present 13 abstracts at the American Heart Association (AHA) Scientific Sessions 2014, taking place in Chicago November 15-19, 2014.

Follow Amgen on Twitter at http://twitter.com/amgen to receive news updates during AHA.

Nov. 18, 2014	Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels
Nov. 12, 2014	Amgen To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions
Nov. 12, 2014	Amgen to Highlight New Data for Investigational Cholesterol-Lowering Medication Evolocumab